Gamma Medica announced in late March that Mercy Medical Center, a member of Catholic Health Services of Long Island, has purchased and installed New York’s first clinical LumaGEM Molecular Breast Imaging (MBI) system.
Gamma Medica announced it has partnered with Hospital Services Limited (HSL), a Dublin, Ireland-based established medical device company that distributes, installs and services radiology capital equipment and medical devices. This partnership will provide women with dense breast tissue access to Gamma Medica’s LumaGEM Molecular Breast Imaging (MBI) system in the United Kingdom, Ireland and the Channel Islands.
Gamma Medica recently announced that through its collaboration with Ohio-based Alpha Imaging, Indiana-based Major Health Partners (MHP) has purchased and installed Gamma Medica’s LumaGEM molecular breast imaging (MBI) system. It is the state’s first LumaGEM and the hospital’s first MBI.
Gamma Medica announced in November that Einstein Medical Center Philadelphia had committed to purchase Pennsylvania’s first clinical LumaGEM Molecular Breast Imaging (MBI) system.
Gamma Medica announced that Henry Ford Health System (Detroit) has purchased Gamma Medica’s LumaGEM Molecular Breast Imaging system. The system is set to be installed by the end of 2016 at Henry Ford West Bloomfield Hospital. The MBI technology will be offered as a secondary screening and diagnostic tool following X-ray mammography, particularly for women with dense breast tissue. This will help improve cancer detection in women who are at greater risk of developing breast cancer.
August 2, 2016 — A retrospective study in American Journal of Roentgenology (AJR) August issue confirmed Gamma Medica’s ...
Gamma Medica, provider of molecular breast imaging technology (MBI), announced it has launched the Be Certain campaign, featuring a dedicated microsite as the cornerstone of an initiative to spread awareness on breast density.
Gamma Medica Inc. announced the Saudi Food and Drug Authority (SFDA) has issued a Medical Device Marketing Authorization (MDMA) for their LumaGEM breast imaging product.
Alpha Imaging, an independent sales and service provider of advanced medical imaging equipment, announced that it has executed a distribution agreement with Gamma Medica Inc. The agreement covers distribution of Gamma Medica's LumaGEM molecular breast imaging (MBI) solution in the Midwest and Mid-Atlantic regions.
At this year's Radiological Society of North America (RSNA) annual meeting, Gamma Medica Inc. invites congress attendees to experience LumaGEM, the latest in molecular breast imaging (MBI).